Mark L. Jordan - Publications, H-index & Citations

Mark L. Jordan

University of California System

40H指数

270论文数

6.1K被引数

收录论文 41

发表时间

Replication protein A inhibitors abrogate ATR kinase signaling and disrupt replication fork dynamics

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Jordan, M.; Oakley, G.; Mayo, L.; Balakrishnan, L.; Turchi, J.

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

BMC CANCER

IF3.4

2019-04-01

OAAI

Parikh, Neil R.; Huiza, Claudia; Patel, Jill S.; Tsai, Sonny; Kalpage, Nathisha; Thein, May; Pitcher, Sage; Lee, Steve P.; Inouye, Warren S.; Jordan, Mark L.; Sanati, Homayoon; Jafari, Lida; Bennett, Carol J.; Gin, Greg E.; Kishan, Amar U.; Reiter, Robert E.; Lewis, Michael; Sadeghi, Ahmad; Aronson, William J.; Garraway, Isla P.; Rettig, Matthew B.; Nickols, Nicholas G.

EVALUATION OF GLOBAL CONTINENTAL UROLOGY RESIDENCY TRAINING PROGRAMS: DISCREPANCIES AND PERCEIVED RESIDENT COMPETENCIES

JOURNAL OF UROLOGY

IF6.8

2016-04-01

OAAI

Okhunov, Zhamshid; Tailly, Thomas; Patruno, Giulio; Vernez, Simone L.; Dutta, Rahul; Fukawa, Stephanie; Garland, Harwood; Juncal, Samuel; Yoon, Renai; Kaler, Kamaljot; Youssef, Ramy; McDougal, Elspeth; Jordan, Mark L.; Landman, Jaime; Clayman, Ralph

Significance of Divergent Expression of Prostaglandin EP4 and EP3 Receptors in Human Prostate Cancer

MOLECULAR CANCER RESEARCH

IF4.7

2013-04-16

OAAI

Huang, Hosea F. S.; Shu, Ping; Murphy, Thomas F.; Aisner, Seena; Fitzhugh, Valerie A.; Jordan, Mark L.

Stable EP4 receptor knockdown inhibits prostate cancer growth in vivo

CANCER RESEARCH

IF16.6

2012-04-01

PREAI

Huang, Hosea; Shu, Ping; Murphy, Thomas; Jordan, Mark

DIFFERENTIAL EXPRESSION OF PROSTAGLANDIN RECEPTORS IN PROSTATE CANCER: A NOVEL THERAPEUTIC TARGET?

JOURNAL OF UROLOGY

IF6.8

2011-04-01

PREAI

Huang, Hosea; Shu, Ping; Murphy, Thomas; Aisner, Seena; Jordan, Mark

PROSTAGLANDIN EP4 RECEPTOR KNOCKDOWN SUPPRESSES PROSTATE CANCER GROWTH IN VIVO

JOURNAL OF UROLOGY

IF6.8

2011-04-01

PREAI

Huang, Hosea; Murphy, Thomas; Shu, Ping; Lewandoski, Patricia; Pregenzer, Gerard; Carpenter, Christina; Jordan, Mark

Prostaglandin receptors differentially regulate prostate cancer growth: A novel treatment target

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Huang, Hosea F.; Shu, Ping; Murphy, Thomas F.; King, Sherita; Wright, Chris; Jordan, Mark L.

A Survey of Women Urology Residents Regarding Career Choice and Practice Challenges

JOURNAL OF WOMENS HEALTH

IF1.9

2009-11-01

PREAI

Jackson, Imani; Bobbin, Mark; Jordan, Mark; Baker, Stephen

Use of modified dendritic cells for the treatment of prostate cancer in mice

JOURNAL OF UROLOGY

IF6.8

2007-04-01

PREAI

Guruli, Georgi; Kancelarich, Renee; Hinds, Peter; Taheri, Sean; Jordan, Mark L.

Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: A single center's experience

TRANSPLANTATION

IF5

2004-03-27

OAAI

Jain, AB; Shapiro, R; Scantlebury, VP; Potdar, S; Jordan, ML; Flohr, J; Marcos, A; Fung, JJ

Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract

TRANSPLANTATION

IF5

2003-12-01

OAAI

Luke, PPW; Herz, DB; Bellinger, MF; Chakrabarti, P; Vivas, CA; Scantlebury, VP; Hakala, TR; Jevnikar, AM; Jain, A; Shapiro, R; Jordan, ML

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning

ANNALS OF SURGERY

IF6.4

2003-10-01

OAAI

Shapiro, R; Jordan, ML; Basu, A; Scantlebury, V; Potdar, S; Tan, HP; Gray, EA; Randhawa, PS; Murase, N; Zeevi, A; Demetris, AJ; Woodward, J; Marcos, A; Fung, JJ; Starzl, TE

Tolerogenic immunosuppression for organ transplantation

LANCET

IF88.5

2003-05-01

392

OAAI

Starzl, TE; Murase, N; Abu-Elmagd, K; Gray, EA; Shapiro, R; Eghtesad, B; Corry, RJ; Jordan, ML; Fontes, P; Gayowski, T; Bond, G; Scantlebury, VP; Potdar, S; Randhawa, P; Wu, T; Zeevi, A; Nalesnik, MA; Woodward, J; Marcos, A; Trucco, M; Demetris, AJ; Fung, JJ

Labetalol-induced hyperkalemia in renal transplant recipients

AMERICAN JOURNAL OF NEPHROLOGY

IF3.2

2002-08-02

PREAI

McCauley, J; Murray, J; Jordan, M; Scantlebury, V; Vivas, C; Shapiro, R

Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN)

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2002-01-01

PREAI

Acker, CG; Flick, R; Shapiro, R; Scantlebury, VP; Jordan, ML; Vivas, C; Greenberg, A; Johnson, JP

Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients

TRANSPLANTATION

IF5

2001-08-01

OAAI

Luke, PPW; Scantlebury, VP; Jordan, ML; Vivas, CA; Hakala, TR; Jain, A; Somani, A; Fedorek, S; Randhawa, P; Shapiro, R

An analysis of early renal transplant protocol biopsies - the high incidence of subclinical tubulitis

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2001-05-01

OAAI

Shapiro, R; Randhawa, P; Jordan, ML; Scantlebury, VP; Vivas, C; Jain, A; Corry, RJ; McCauley, J; Johnston, J; Donaldson, J; Gray, EA; Dvorchik, I; Hakala, TR; Fung, JJ; Starzl, TE

Inhibition of the allograft response by donor specific blood transfusion:: Association with reduced local Th1 cytokines and nitric oxide but enhanced prostaglandin E2 production

TRANSPLANTATION

IF5

2000-12-01

PREAI

Koga, S; Luke, PP; Specht, SM; Rominski, B; Jaquins-Gerstl, A; Hoffman, RA; Thomson, AW; Jordan, ML

Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression

TRANSPLANTATION

IF5

2000-09-01

OAAI

Chakrabarti, P; Wong, HY; Scantlebury, VP; Jordan, ML; Vivas, C; Ellis, D; Lombardozzi-Lane, S; Hakala, TR; Fung, JJ; Simmons, RL; Starzl, TE; Shapiro, R

研究方向